Private Member’s Bill proposes second-tier New Zealand “advancement patent”

A New Zealand “innovation (or advancement) patent”?  Now distinctly possible.  Australia’s second-tier innovation patent regime has been all over the news recently – literally overnight, it went from death row to receiving a stay of execution. Although it is not without its faults, has been prone to certain unintended outcomes and has recently gained some

Injunction appeal success leaves generics companies in a world of pain

Warner-Lambert and the Pfizer group successfully appealed to the Full Federal Court to broaden the scope of an interlocutory injunction restraining the supply of Apotex’s pregabalin products (Warner-Lambert Company LLC v Apotex Pty Ltd [2014] FCAFC 59). This decision suggests that efforts made by generics companies to restrict the registration of a bioequivalent pharmaceutical product

Final Report for Pharmaceutical Patents Review released but Government distances itself from the Report

Despite the Minister for Industry, Ian Macfarlane, announcing in Parliament on 11 February 2014 that the Government had no plans to release the Final Report for the Pharmaceutical Patents Review (see Patent Term Extensions are here to stay … for now), the Government has now backtracked and released the Final Report “in response to stakeholder

Methods of medical treatment held patent eligible

Australia’s highest court has recently confirmed that patents are available for the broad grounds of methods of medical treatment. In Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd, Sanofi had been granted a patent for a new use of a known medical compound leflumonide. The new use was in the treatment of a variant of

NZ Patents Act 2013 to commence by 13 September 2014

Recent articles in this series have reported on the passage of New Zealand’s new Patents Act 2013 – and some of its content. We did, however, note that the final step in the legislative process was for the new Act to receive Royal Assent; this duly happened on 13 September 2013. The net result is

New Zealand hits ‘Go’ on new Patent law

In late August 2013 the New Zealand Patents Bill passed its final reading in Parliament. When it comes into effect, anticipated to be around a year away, it will make sweeping changes to New Zealand patent law across the board. In our article of last week, we introduced the new Act and some of the

Page 1 of 3123